Scientists discovered that certain gene changes allow cells to function even when frataxin, the protein lost in Friedreich’s ataxia, is missing. Experiments in worms, human cells, and mice revealed ...

Abstract: In this paper, a greedy initialization-based genetic algorithm is proposed for unit-norm tight frame sampling design in spherical near-field measurements. Since the optimization criterion ...

The search space is the set of all complete 81-cell assignments, not partial states. Cost function / fitness: count the number of constraint violations. Goal: minimize violations to 0. This reframing ...

The FDA has approved Otarmeni, the first gene therapy for genetic hearing loss, through its National Priority Voucher program. The therapy is indicated for pediatric and adult patients with ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. Subscribe to read this story ad-free Get unlimited access to ad-free ...

Credit: Regeneron. Supported by the CHORD trial, this AAV vector-based therapy delivers a working copy of the OTOF gene and restores otoferlin protein production. Regeneron will be providing Otarmeni ...

There have been many travel disruptions so far in 2026. They include events such as the war in Iran, military operation in Venezuela, cartel violence in Mexico, an East Coast blizzard and the ongoing ...

A new study reveals all five fundamental nucleobases – the molecular “letters” of life – have been detected in samples from the asteroid Ryugu. Asteroid particles offer a glimpse into the chemical ...

WASHINGTON, March 10 (Reuters) - The U.S. FDA approved leucovorin, a decades-old generic drug, to treat a rare genetic disorder which causes autism-like symptoms on Tuesday, but not for children with ...

The FDA has approved expanded use of leucovorin calcium tablets (Wellcovorin, GSK) for treatment of adults and children with cerebral folate deficiency and a confirmed variant in the folate receptor 1 ...

The prescription drug leucovorin is getting a label update, but it’s not what that the US Food and Drug Administration suggested during a White House briefing in September, when officials touted the ...